What is the SABS stock price prediction for next 2 weeks?

According to our price prediction algorithm,SAB Biotherapeutics, Inc. (SABS) price will be around $3.94 in the next 2 weeks. This means it will increase by 2.6250000000000004 from the last closing price. This prediction may vary from other time period filters for SABS stock.

What can be the highest Possible price of SABS stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, SABS can achieve the highest price of $4.14 which is 7.713127223422957 higher than last closing price. This prediction may vary from other time period filters for SABS stock.

What can be the lowest Possible price of SABS stock in next 2 weeks?

As per the forecast and algorithmic analysis, SABS stock price can be as low as $3.75 which is -2.436283167833303 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for SABS stock.

Will SABS stock go high in the next 2 weeks?

Yes, our stock forecasting algorithm shows that SABS stock will gain2.6250000000000004 in the next 2 weeks. This prediction may vary from other time period filters for SABS stock.

What is SABS stock last closing price?

Last closing price of SABS stock was $3.84.

What is SABS stock price prediction?

SABS stock price prediction means predicting the future closing prices of SABS stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of SABS stock in a certain time period.

How we predict SABS stock future prices?

If you are searching for SABS stock forecast, analysis or price prediction, then you might be wondering what SAB Biotherapeutics, Inc. (SABS) will do in the future. Our SABS price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This SABS price prediction will likely answer most of your questions.

How frequent we update SABS stock predictions?

We are updating the forecasts for the SABS stock on daily basis.

Is using ML forecasting for SABS stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for SABS stock same for all the time periods?

No, the prediction for SABS stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

SAB Biotherapeutics, Inc. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$3.842.13%Since 2 Weeks

Predicted Price$3.942.63%For 2 Weeks

Upper Predicted Price$4.147.71%For 2 Weeks

Lower Predicted Price$3.75-2.44%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of SABS will rise by +2.63% over the next 2 Weeks and hit $3.94 by Monday, January 5, 2026. In that time frame, SABS's share price is expected to range between $3.75 and $4.14.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
Jan 5, 2026	3.75	3.94	4.14
Jan 2, 2026	3.81	4.00	4.21
Jan 1, 2026	3.62	3.81	4.00
Dec 31, 2025	3.76	3.97	4.17
Dec 30, 2025	3.80	4.00	4.19
Dec 29, 2025	3.70	3.91	4.09
Dec 26, 2025	3.79	3.98	4.17
Dec 25, 2025	3.59	3.78	3.98
Dec 24, 2025	3.76	3.94	4.14
Dec 23, 2025	3.77	3.97	4.17

SABS shares remained flat 0 in Tuesday, December 23, 2025's trading session, starting and closing at a previous close of $3.84 to move at $3.84. The stock demonstrated notable intraday movement (see SABS's key stats for a full breakdown), fluctuating between $3.77 and $4.00, a +6.10% trading range. While recent weeks have seen some volatility, SABS has managed to secure a +8.17% gain over the past 2 weeks. The neutral price movement was accompanied by decreased trading volume, with approximately 127.64K shares changing hands, 696.59K fewer than the previous session. This amounted to $490.14K in total market activity.

Will SABS Continue Its Upward Trend?

According to analyst ratings and projections for SABS, SAB Biotherapeutics, Inc. shares are anticipated to increase by +7.16%, potentially reaching $4.14 per share by January 5, 2026. Short-term technical indicators currently suggest a neutral sentiment for SABS. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the SABS stock forecast, now is a good time to buy SABS stock because its current trading price is -2.56% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on SABS covering social and institutional perspectives.

SABS Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into SABS's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 50.87% to 56.09%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 57.42%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 54.75%, maintains a neutral outlook for the long term. Insights into SABS's shareholder base show how institutional investors are positioning themselves during these momentum shifts

SAB Biotherapeutics Short-Term Forecasts

SABS Forecast For Next 5 Days

Our algorithm anticipates SAB Biotherapeutics (SABS) stock could hit $3.82 by Dec 30, 2025. This represents a -0.61% rise from today's price, following a +0.79% change over the past five days.

SABS Forecast For Next 30 Days

Based on analysis of market trends, the outlook for SAB Biotherapeutics, Inc. (SABS) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $3.78, which would mean a -1.56% decrease from the current price of $3.84. Projections for this period range from a high of $4.24 to a low of $3.31.

SABS Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for SAB Biotherapeutics's price over the next three months point to a rise. SABS stock is expected to peak at $11.32 on Jan 20, 2026 before potentially dipping to $8.48 on Feb 11, 2026. On average, SABS is likely to trade around $9.93 in the coming 90 days.

SAB Biotherapeutics Stock Forecast 2025

Based on our predictive models, SAB Biotherapeutics (SABS) is expected to trade between $9.18 and $10.00 throughout 2025. This would result in an average price of $9.54, potentially offering investors a +148.44% return from current levels.

SAB Biotherapeutics, Inc. Monthly Forecast 2025–2026

December 2025

According to our latest forecast models, SAB Biotherapeutics, Inc. (SABS) is positioned to show a strong performance in December 2025. The price is predicted to move between $9.18 and $10.00, settling at an average of $9.54. This could translate to a +148.44% gain.

January 2026

Based on current market signals, SAB Biotherapeutics, Inc. is projected to trend january 2026. We forecast a trading range from $9.28 to $11.32, with a likely average price of $10.44. Investors could expect a potential return of +171.88%.

February 2026

Our predictive algorithms indicate SAB Biotherapeutics, Inc. stock may see a shift in February 2026. The expected range spans $8.48–$10.23, with an average target of $9.19. This represents a positive outlook and a possible gain of +139.32%.

March 2026

Analyzing established trends, SAB Biotherapeutics, Inc. looks set to move in March 2026. Projections place the stock between $9.45 and $11.38, averaging around $10.51. This suggests a +173.70% gain from current levels.

April 2026

Market indicators suggest SAB Biotherapeutics, Inc. could experience notable changes during April 2026. Prices could fluctuate within $10.31 to $14.93, with a midpoint forecast of $12.69. The stock might deliver a +230.47% gain.

May 2026

Forecasting for May 2026, models estimate that SAB Biotherapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $11.87 and $15.15, averaging $13.65. This signals a positive trajectory with potential returns around +255.47%.

June 2026

According to our latest forecast models, SAB Biotherapeutics, Inc. (SABS) is positioned to show a strong performance in June 2026. The price is predicted to move between $12.09 and $17.04, settling at an average of $15.23. This could translate to a +296.61% gain.

July 2026

Based on current market signals, SAB Biotherapeutics, Inc. is projected to trend july 2026. We forecast a trading range from $11.34 to $18.66, with a likely average price of $15.04. Investors could expect a potential return of +291.67%.

August 2026

Our predictive algorithms indicate SAB Biotherapeutics, Inc. stock may see a shift in August 2026. The expected range spans $12.61–$22.22, with an average target of $18.02. This represents a positive outlook and a possible gain of +369.27%.

September 2026

Analyzing established trends, SAB Biotherapeutics, Inc. looks set to move in September 2026. Projections place the stock between $10.32 and $21.53, averaging around $16.47. This suggests a +328.91% gain from current levels.

October 2026

Market indicators suggest SAB Biotherapeutics, Inc. could experience notable changes during October 2026. Prices could fluctuate within $10.25 to $28.59, with a midpoint forecast of $18.23. The stock might deliver a +374.74% gain.

November 2026

Forecasting for November 2026, models estimate that SAB Biotherapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $14.13 and $33.12, averaging $24.27. This signals a positive trajectory with potential returns around +532.03%.

December 2026

According to our latest forecast models, SAB Biotherapeutics, Inc. (SABS) is positioned to show a strong performance in December 2026. The price is predicted to move between $12.02 and $29.54, settling at an average of $21.10. This could translate to a +449.48% gain.

SABS's history of dividends and stock splits also plays a role in long-term investor confidence.